University of Sussex
Browse

File(s) not publicly available

Business strategy and access to medicines in developing countries

journal contribution
posted on 2023-06-08, 17:37 authored by Anne Roemer-MahlerAnne Roemer-Mahler
The availability of generic ARVs was important for the expansion of treatment in developing countries. This paper argues that it is therefore imperative to examine which factors have shaped generics companies’ decisions to supply these drugs. This will help us better understand the development of the global AIDS response in the past and how to address some of its future challenges. This paper illustrates the value of combining the investigation of political and economic dynamics with a focus on how they affect the commercial considerations of companies that supply products required by society. In doing so it contributes to the existing literature on business in global governance, which tends to focus on how business affects states’ decision-making but neglects how global governance influences companies’ decisions to produce some goods and not others.

History

Publication status

  • Published

Journal

Global Health Governance

ISSN

1939-2389

Publisher

Seton Hall University Center for Global Health Studies

Issue

1

Volume

4

Department affiliated with

  • International Relations Publications

Full text available

  • No

Peer reviewed?

  • Yes

Legacy Posted Date

2014-06-17

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC